News | Coronavirus (COVID-19) | March 12, 2021

COVID-19 Blood Vessel Damage May Cause Brain Fog and Other Long-hauler Symptoms

Lack of oxygen, increased inflammation affects serotonin levels in brain

Interactions between capillary function, inflammation, hypoxia, and neurotransmission. The expression of ACE2 and other SARS‐CoV‐2 entry factors on parenchymal cells and observations of infected cells in biopsy material hold important clues to understand COVID‐19‐related organ damage. COVID-19 Blood Vessel Damage May Cause Brain Fog and Other Long-hauler Symptoms

Interactions between capillary function, inflammation, hypoxia, and neurotransmission. The expression of ACE2 and other SARS‐CoV‐2 entry factors on parenchymal cells and observations of infected cells in biopsy material hold important clues to understand COVID‐19‐related organ damage. Find more figures and read the full study.


March 12, 2021 — A new review suggests that blood vessel damage and impaired oxygen delivery related to COVID-19 play a role in mood changes and cognitive difficulties that people with the disease face during illness and recovery. The review was published in Physiological Reports in February.[1] The article offers insights into the reason why some ling-hauler COVID patients have persistent symptoms months after their infections. While the the "brain fog" and cognitive issues are most evident in many of the long-hauler patients, there are concerns over of physiological issues, including the impact on the heart.

COVID-19, the disease caused by the SARS CoV-2 virus, may cause a wide range of symptoms ranging from lack of taste and smell, muscle weakness and fatigue to acute respiratory distress syndrome and multiple organ failure. Changes in blood flow and microscopic clots in the body’s smallest blood vessels can also affect people with the disease. “While most symptoms disappear over the weeks and months following the infection, the extent of long-term COVID-19 [complications] remains unclear,” the authors of the review wrote.

One cluster of symptoms people with COVID-19 have experienced — even after active infection has passed — is cognitive or mood impairment. This may include memory problems, depression, anxiety and the inability to focus or concentrate, which is called “brain fog.” Previous research has found that people with a diagnosis of mild cognitive impairment or Alzheimer’s disease show “widespread cerebral microvascular flow disturbances.” The current review explains that in people with COVID-19, a shortened blood flow transit time in the capillaries limits the amount of oxygen that can be delivered to the lungs and brain.

Low oxygen levels and the increase in inflammatory cytokines — proteins involved in immune system signaling — that occur with COVID-19 can also affect serotonin levels. Serotonin is a neurotransmitter the brain produces to regulate mood. Low levels of serotonin have been linked to anxiety and lowered mood. Oxygen is crucial for the production of serotonin, and research suggests cytokines reduce serotonin levels. “These mechanisms could affect cognitive functions and quality of life for COVID-19 patients,” the reviewers wrote.

Other findings discussed in the review include:

   • The recovery of COVID-19 patients may rely on the restoration of normal blood flow through the body’s smallest blood vessels.
   • Development of new blood vessels in COVID-19 may form shunts for blood delivery through the lungs and contribute to poor blood oxygenation.

Read the full article, “SARS CoV‐2 related microvascular damage and symptoms during and after COVID‐19: Consequences of capillary transit‐time changes, tissue hypoxia and inflammation,” published in Physiological Reports.

 

Related COVID-19 Cardiology Content:

The Long-term Cardiovascular Impact of COVID-19

COVID-19 Changes Properties Blood Cells

VIDEO: Antithrombotic Prophylaxis in COVID-19 Patients — Interview with Behnood Bikdeli M.D.

Coronavirus Disease 2019 (COVID-19) and the Heart—Is Heart Failure the Next Chapter?

PHOTO GALLERY: How COVID-19 Appears on Medical Imaging

Heart Damage Found in More Than Half of COVID-19 Patients Discharged From Hospitals

Overview of Randomized Trials of Antithrombotic Therapy for COVID-19 Patients 

COVID-19 Can Kill Heart Cells and Interfere With Contraction

 

Reference:

1. Leif Østergaard. SARS CoV‐2 related microvascular damage and symptoms during and after COVID‐19: Consequences of capillary transit‐time changes, tissue hypoxia and inflammation. Physiology Reports. First published online 1 February 2021. https://doi.org/10.14814/phy2.14726.

 


Related Content

News | Coronavirus (COVID-19)

January 25, 2024 — New research confirms what public health leaders have been fearing: the significant uptick in the ...

Home January 25, 2024
Home
News | Coronavirus (COVID-19)

January 11, 2024 — Acute cardiovascular manifestations of COVID-19, such as heart failure, thrombosis, and dysrhythmia ...

Home January 11, 2024
Home
News | Coronavirus (COVID-19)

December 14, 2023 — Individuals infected with COVID-19 are also at an increased risk of suffering from heart rhythm ...

Home December 14, 2023
Home
News | Coronavirus (COVID-19)

October 16, 2023 — A door-to-balloon (D2B) time of 90-minutes or less is associated with improved outcomes for heart ...

Home October 16, 2023
Home
News | Coronavirus (COVID-19)

October 11, 2023 — Unvaccinated people who have recovered from COVID-19 are at heightened risk of heart complications ...

Home October 11, 2023
Home
News | Coronavirus (COVID-19)

September 26, 2023 — New research from the Smidt Heart Institute at Cedars-Sinai shows that patients who went to a ...

Home September 26, 2023
Home
News | Coronavirus (COVID-19)

June 19, 2023 — Patients who had heart attacks during the first COVID-19 lockdown in the UK and Spain are predicted to ...

Home June 19, 2023
Home
News | Coronavirus (COVID-19)

June 14, 2023 — A University of Waterloo engineer’s MRI invention reveals better than many existing imaging technologies ...

Home June 14, 2023
Home
News | Coronavirus (COVID-19)

June 9, 2023 — Patients infected with beta and delta COVID-19 variants, and those who required hospital stays for COVID ...

Home June 09, 2023
Home
News | Coronavirus (COVID-19)

May 31, 2023 — Cytomegalovirus (CMV) is one of the most prevalent herpesviruses worldwide. Depending on the geographical ...

Home May 31, 2023
Home
Subscribe Now